TiGenix: TiGenix to participate or present at key conferences in the second half of 2014

Posted: September 16, 2014 at 12:51 am

SEPTEMBER 15, 2014

TiGenix to participate or present at key conferences in the second half of 2014

Leuven (BELGIUM) - September 15, 2014 - TiGenix NV (Euronext Brussels: TIG), an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from its proprietary platform of allogeneic, expanded adipose-derived stem cells, or eASC's, in inflammatory and autoimmune diseases, announced today the list of conferences in which it will participate during the second half of 2014.

15-16 September Stem Cells & Regenerative Medicine Congress 2014, Boston, USA Participant: Claudia Jimenez, Senior Director Business Development

17 September Regener8, Leeds, UK Presenter: Wilfried Dalemans, Chief Technical Officer

30 September-1 October 14th Biotech in Europe Forum for Global Partnering and Investing, Basel, Switzerland Participant: Claudia Jimenez, Senior Director Business Development

2-3 October 14th Large & Midcap Event, Paris, France Participant: Claudia D'Augusta, Chief Financial Officer

6-8 October Stem Cell Meeting on the Mesa, California, USA Presenter: Eduardo Bravo, Chief Executive Officer

18-22 October 22nd United European Gastroenterology Week (UEGW), Vienna, Austria Participant: Mary Carmen Diez, VP Medical Affairs and New Product Commercialisation

3-5 November BIO-Europe 2014, Frankfurt, Germany Participant: Claudia Jimenez, Senior Director Business Development

Read more here:
TiGenix: TiGenix to participate or present at key conferences in the second half of 2014

Related Posts